News und Analysen
Turkiye Garanti Bankasi A.S.: Changes in Top Management
Correction: Notification of managers’ transactions
Partners Group portfolio company Esentia Energy Development prices IPO and lists on Mexican Stock Exchange
Schindler Holding Ltd.: Change to the Group Executive Committee
Copart Reports First Quarter Fiscal 2026 Financial Results
Copart, Inc. (NASDAQ: CPRT) today reported financial results for the quarter ended October 31, 2025.
For the three months ended October 31, 2025, revenue, gross profit, and net income
T-Mobile Extends Partnership with FORMULA 1 HEINEKEN LAS VEGAS GRAND PRIX, Expands Role as Regional 5G Innovation Partner of Formula 1®
T-Mobile (NASDAQ: TMUS) today announced a multi-year extension as the Exclusive 5G Partner of the FORMULA 1 HEINEKEN LAS VEGAS GRAND PRIX and an expansion to become the Regional 5G Innovation
Morgan Stanley Sustainable Signals: Global Survey Shows Institutional Investors Maintain Positive Outlook on Sustainable Investing
The majority of asset owners and managers globally expect allocations to sustainable funds to increase in the next two years, according to a new “Sustainable Signals” report by the Morgan Stanley
Intuit Appoints Enterprise AI Leader Bill McDermott and Financial Technology Innovator Adena Friedman to Board of Directors
Intuit Inc. (Nasdaq: INTU), the global financial technology platform that makes Intuit TurboTax, Credit Karma, QuickBooks, and Mailchimp, today announced the appointment of Bill McDermott, Chairman
New Survey Offers Important Insights into How Medicare Advantage Beneficiaries Use and Value Their Supplemental Benefits
A recent study conducted by Humana Healthcare Research, with strategic input from researchers at the University of Pennsylvania, reveals key insights into how Medicare Advantage beneficiaries
U.S. FDA Approves HYRNUO® (sevabertinib) for Previously Treated Patients with HER2-Mutated Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Bayer announced today that the U.S. Food and Drug Administration (FDA) has approved HYRNUO® (sevabertinib), an oral, reversible, tyrosine kinase inhibitor (TKI), for the treatment of adult patients
Turkiye Garanti Bankasi A.S.: Regarding the Sale of Non-Performing Loans Portfolio
Turkiye Garanti Bankasi A.S.: Announcement Regarding the Loan Agreement Signed with ICO
Union Pacific Corporation Declares Fourth Quarter 2025 Dividend
The Board of Directors of Union Pacific Corporation (NYSE: UNP) has declared a quarterly dividend of $1.38 per share on the company’s common stock, payable Dec. 30, 2025, to shareholders of record
Less Paperwork, More Connected Care: Humana and Epic Advance Data Sharing
Humana Inc. [NYSE: HUM] today announced the broad activation of Epic’s Coverage Finder and Digital Insurance Card Exchange capabilities for its Medicare Advantage membership – marking a significant
Brotherhood of Railway Carmen Reaches Agreement with Union Pacific to Protect ‘Good Paying Railroad Jobs’
The Brotherhood of Railway Carmen (BRC) and Union Pacific Railroad reached an agreement that provides a commitment of job security for hundreds of union employees after Union Pacific and Norfolk
Morgan Stanley Declares Dividends on Its Preferred Stock
Morgan Stanley today declared a regular dividend on the outstanding shares of each of the following preferred stock issues:
-
Floating Rate Non-Cumulative Preferred Stock, Series A - $310.89 per
Turkiye Garanti Bankasi A.S.: Prospectus – Capital Markets Instrument Note
Turkiye Garanti Bankasi A.S.: Prospectus - Summary
Ørsted to commercialise its state-of-the-art low-noise technology Osonic: Signs first agreement with Luxcara
Partners Group appoints Nicholas Smith Wang as Partner and Co-Head of Private Equity Technology
Swiss Life continues to grow in the first nine months of 2025
Copart, Inc. to Release First Quarter Fiscal 2026 Results
Copart, Inc. (NASDAQ: CPRT) announced today that it will release earnings for the first quarter of fiscal 2026 after 4:00 p.m. Eastern Time (3:00 p.m. Central) on Thursday, November 20, 2025.
On